inhibiting < inhibition < inhibitor

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f KwdFr.f

List of bibliographic references indexed by inhibition

Number of relevant bibliographic references: 58.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000111 (2021)	L. Ratiani ; S. Gegechkory ; K. Machavariani ; T. Shotadze ; T. Sanikidze [Géorgie (pays)] ; N. Intskirveli	THE PECULIARITY OF COVID- 19 GENOME AND THE CORONAVIRUS RNA TRANSLATION PROCESS AS APOTENTIAL TARGET FOR ETIOTROPIC MEDICATIONSWITH ADENINE AND OTHER NUCLEOTIDE ANALOGUES (REVIEW).
000127 (2021)	Thirumal Kumar D [Inde] ; Nishaat Shaikh [Inde] ; Udhaya Kumar S [Inde] ; George Priya Doss C [Inde] ; Hatem Zayed [Qatar]	Structure-Based Virtual Screening to Identify Novel Potential Compound as an Alternative to Remdesivir to Overcome the RdRp Protein Mutations in SARS-CoV-2.
000233 (2021)	Olfa Noureddine [Tunisie] ; Noureddine Issaoui [Tunisie] ; Mouna Medimagh [Tunisie] ; Omar Al-Dossary [Arabie saoudite] ; Houda Marouani [Tunisie]	Quantum chemical studies on molecular structure, AIM, ELF, RDG and antiviral activities of hybrid hydroxychloroquine in the treatment of COVID-19: Molecular docking and DFT calculations.
000264 (2021)	Yanqiang Han ; Zhilong Wang ; Jiahao Ren ; Zhiyun Wei ; Jinjin Li [République populaire de Chine]	Potential inhibitors for the novel coronavirus (SARS-CoV-2).
000292 (2021)	Hesham Refaat [Égypte] ; Fatma M. Mady [Égypte] ; Hatem A. Sarhan [Égypte] ; Heba S. Rateb [Égypte] ; Eman Alaaeldin [Égypte]	Optimization and evaluation of propolis liposomes as a promising therapeutic approach for COVID-19.
000346 (2021)	Hardeep Singh Tuli [Inde] ; Shivani Sood ; Jagjit Kaur [Australie] ; Pawan Kumar [Israël] ; Prachi Seth ; Sandeep Punia [Inde] ; Priya Yadav [Inde] ; Anil Kumar Sharma [Inde] ; Diwakar Aggarwal [Inde] ; Katrin Sak [Estonie]	Mechanistic insight into anti-COVID-19 drugs: recent trends and advancements.
000365 (2021)	Esben B. Svenningsen [Danemark] ; Jacob Thyrsted [Danemark] ; Julia Blay-Cadanet [Danemark] ; Han Liu [Danemark] ; Shaoquan Lin [Danemark] ; Jaime Moyano-Villameriel [Danemark] ; David Olagnier [Danemark] ; Manja Idorn [Danemark] ; S Ren R. Paludan [Danemark] ; Christian K. Holm [Danemark] ; Thomas B. Poulsen [Danemark]	Ionophore antibiotic X-206 is a potent inhibitor of SARS-CoV-2 infection in vitro.
000373 (2021)	Irina Panovska-Stavridis ; Nevenka Ridova ; Tatjana Stojanoska ; Ilir Demiri ; Milena Stevanovic ; Simona Stojanovska ; Tara Ristevska ; Aleksandar Dimkovski ; Venko Filipce ; Aleksandar Dimovski ; Aleksandra Grozdanova	Insight in the Current Progress in the Largest Clinical Trials for Covid-19 Drug Management (As of January 2021).
000375 (2021)	Mustafa M. Kadhim [Iraq] ; Abbas Washeel Salman [Iraq] ; Ameerah Mrebee Zarzoor [Iraq] ; Wesam R. Kadhum [Iraq]	Inhibition of SARS-CoV-2 reproduction using Boswellia carterii: A theoretical study.
000383 (2021)	Haruna I. Umar [Nigeria] ; Sunday S. Josiah [Nigeria] ; Tolulope P. Saliu [Nigeria] ; Tajudeen O. Jimoh [Thaïlande] ; Adeola Ajayi [Nigeria] ; Jamilu B. Danjuma [Nigeria]	In-silico analysis of the inhibition of the SARS-CoV-2 main protease by some active compounds from selected African plants.
000402 (2021)	Tianling Ou [États-Unis] ; Huihui Mou [États-Unis] ; Lizhou Zhang [États-Unis] ; Amrita Ojha [États-Unis] ; Hyeryun Choe [États-Unis] ; Michael Farzan [États-Unis]	Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2.
000441 (2021)	Asokan Devarajan [États-Unis] ; Marmar Vaseghi [États-Unis]	Hydroxychloroquine can potentially interfere with immune function in COVID-19 patients: Mechanisms and insights.
000532 (2021)	Shadma Wahab ; Md Faruque Ahmad ; Arshad Hussain ; Shazia Usmani ; Ambreen Shoaib ; Wasim Ahmad	Effectiveness of Azithromycin as add-on Therapy in COVID-19 Management.
000570 (2021)	Julia Werner [Allemagne] ; Raphael M. Kronberg [Allemagne] ; Pawel Stachura [Allemagne] ; Philipp N. Ostermann [Allemagne] ; Lisa Müller [Allemagne] ; Heiner Schaal [Allemagne] ; Sanil Bhatia [Allemagne] ; Jakob N. Kather [Allemagne] ; Arndt Borkhardt [Allemagne] ; Aleksandra A. Pandyra [Allemagne] ; Karl S. Lang [Allemagne] ; Philipp A. Lang [Allemagne]	Deep Transfer Learning Approach for Automatic Recognition of Drug Toxicity and Inhibition of SARS-CoV-2.
000571 (2021)	Mukesh Kumar [Inde] ; Jitender Madan [Inde] ; Rupinder Kaur Sodhi [Inde] ; Shashi Bala Singh [Inde] ; Anju Katyal [Inde]	Decoding the silent walk of COVID-19: Halting its spread using old bullets.
000631 (2021)	Mohammad Bahadoram [Iran] ; Bijan Keikhaei [Iran] ; Ali Saeedi-Boroujeni [Iran] ; Mohammad-Reza Mahmoudian-Sani [Iran]	Chloroquine/hydroxychloroquine: an inflammasome inhibitor in severe COVID-19?
000637 (2021)	Jun-Ichi Okada [Japon] ; Takashi Yoshinaga [Japon] ; Takumi Washio [Japon] ; Kohei Sawada [Japon] ; Seiryo Sugiura [Japon] ; Toshiaki Hisada [Japon]	Chloroquine and hydroxychloroquine provoke arrhythmias at concentrations higher than those clinically used to treat COVID-19: A simulation study.
000638 (2021)	Tariq A. Altalhi [Arabie saoudite] ; Khaled Alswat [Arabie saoudite] ; Walaa F. Alsanie [Arabie saoudite] ; Mohamed M. Ibrahim [Arabie saoudite, Égypte] ; Ali Aldalbahi [Arabie saoudite] ; Hamdy S. El-Sheshtawy [Égypte]	Chloroquine and hydroxychloroquine inhibitors for COVID-19 sialic acid cellular receptor: Structure, hirshfeld atomic charge analysis and solvent effect.
000738 (2021)	Meetali Sinha [Inde] ; Anshika Gupta [Inde] ; Shristee Gupta [Inde] ; Prakrity Singh [Inde] ; Shraddha Pandit [Inde] ; Shweta Singh Chauhan [Inde] ; Ramakrishnan Parthasarathi [Inde]	Analogue discovery of safer alternatives to HCQ and CQ drugs for SAR-CoV-2 by computational design.
000914 (2020)	Muhammad Hamza [République populaire de Chine, Pakistan] ; Ashaq Ali [République populaire de Chine] ; Suliman Khan [République populaire de Chine] ; Saeed Ahmed [République populaire de Chine] ; Zarlish Attique [Pakistan] ; Saad Ur Rehman [Pakistan] ; Ayesha Khan [Pakistan] ; Hussain Ali [Pakistan] ; Muhammad Rizwan [Pakistan] ; Anum Munir [Pakistan] ; Arshad Mehmood Khan [Pakistan] ; Faiza Siddique [Pakistan] ; Azhar Mehmood [Pakistan] ; Faisal Nouroz [Pakistan] ; Sajid Khan [Pakistan]	nCOV-19 peptides mass fingerprinting identification, binding, and blocking of inhibitors flavonoids and anthraquinone of Moringa oleifera and hydroxychloroquine.
000983 (2020)	Mohammed H. Shalayel [Arabie saoudite] ; Ghassab M. Al-Mazaideh [Arabie saoudite] ; Saleem H. Aladaileh [Arabie saoudite] ; Farhan K. Al-Swailmi [Arabie saoudite] ; Mohammad G. Al-Thiabat [Malaisie]	Vitamin D is a potential inhibitor of COVID-19: In silico molecular docking to the binding site of SARS-CoV-2 endoribonuclease Nsp15.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "inhibition" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "inhibition" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    inhibition
}}

---

This area was generated with Dilib version V0.6.38. Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021